Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Laufer

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
EMBO Molecular Medicine|November 5, 2019
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathyMaksymilian Prondzynski, Marc D Lemoine, Antonia Tl Zech, et al.
Redox Biology|September 28, 2024
Physioxia rewires mitochondrial complex composition to protect stem cell viabilityJanice Raabe, Ilka Wittig, Patrick Laurette, et al.
Der Urologe. Ausg. A|April 20, 2018
[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]H Ahmadzadehfar, P Albers, A Bockisch, et al.
The Journal of Clinical Investigation|April 4, 2023
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathyFabian Braun, Ahmed Abed, Dominik Sellung, et al.
The EMBO Journal|October 28, 2025
Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragmentFatih Demir, Elina Kovalenko, Moritz Lassé, et al.
Nature Communications|August 14, 2023
An integrated organoid omics map extends modeling potential of kidney diseaseMoritz Lassé, Jamal El Saghir, Celine C Berthier, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
EMBO Molecular Medicine|November 5, 2019
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathyMaksymilian Prondzynski, Marc D Lemoine, Antonia Tl Zech, et al.
Redox Biology|September 28, 2024
Physioxia rewires mitochondrial complex composition to protect stem cell viabilityJanice Raabe, Ilka Wittig, Patrick Laurette, et al.
Der Urologe. Ausg. A|April 20, 2018
[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]H Ahmadzadehfar, P Albers, A Bockisch, et al.
The Journal of Clinical Investigation|April 4, 2023
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathyFabian Braun, Ahmed Abed, Dominik Sellung, et al.
The EMBO Journal|October 28, 2025
Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragmentFatih Demir, Elina Kovalenko, Moritz Lassé, et al.
Nature Communications|August 14, 2023
An integrated organoid omics map extends modeling potential of kidney diseaseMoritz Lassé, Jamal El Saghir, Celine C Berthier, et al.
Pageof 18